| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |